Menu

Monsanto and Bayer Announce Approval of Massive Merger

On Tuesday, shareholders at the agribusiness giant approved the $66 billion deal with the European pharmaceutical firm.

Dec 13, 2016
Bob Grant

WIKIMEDIA, LARS PLOUGHMANNIn a move that has been anticipated for months, agribusiness corporation Monsanto has taken another step towards finalizing a $66 billion merger with Bayer AG, the Germany-based pharma and chemical firm. On Tuesday (December 13) Monsanto’s shareholders overwhelmingly approved the $128 per share price paid by Bayer for the acquisition.  The new entity will represent the world’s largest agriculture and chemical company.

“This is a really significant milestone,” Monsanto CEO Hugh Grant told the St. Louis Post-Dispatch. “When you get 99 percent affirmation, that's very encouraging.”

But outside of the 99 percent of Monsanto shareholders who approved the deal, one individual filed a lawsuit to stop it, alleging that the shares were worth more than $128 a piece. That suit was thrown out by a St. Louis County judge.

The National Farmers Union has also spoken out against the deal. “Consolidation of this magnitude cannot be the standard for agriculture, nor should we allow it to determine the landscape for our future,” the organization said in a statement posted in September, when the merger was first announced. The Natural Resources Defense Council (NRDC) sent a letter on December 12 to the Department of Justice, also opposing the merger. “While, standing alone, a proposal for the takeover of the world's largest producer of genetically modified seeds by the world's second largest producer of pesticides is problematic, it is also part of a troubling trend of consolidation in the agricultural sector,” the letter read. Rebecca Riley, senior attorney in the Natural Resources Defense Council’s (NRDC) Land & Wildlife program, also railed against the merger. “If you are a farmer, consumer, or any of the pollinators critical to our nation’s food supply—such as the bees and monarch butterflies facing massive new threats from pesticides in recent years—this big business merger could be very bad news,” she wrote in a blog post on the NRDC’s website.

The deal is expected to close at the end of 2017, after anti-trust regulators in the U.S. Europe, Brazil, India, and China review and OK it.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!